Cipla Health Calls for Awareness on Correct ORS Selection with Prolyte ORS

Bhubaneswar, December 15, 2025 – ProlyteORS, the flagship brand from Cipla Health Limited, reiterates the importance ofconsuming Oral Rehydration Solutions that use the World Health Organisation (W.H.O.) approved formula and clearly labelled as such on the packaging, a standard recognised by the government of India through its inclusion in the National List of Essential Medicines (NLEM).

This formulation, followed by ProlyteORS, comprises a scientifically defined ratio of water, electrolytes and glucose with a total osmolarity of 245—the only globally endorsed benchmark for effective therapeutic rehydration.

Cipla Health also advocates the use of pre-made formulations to avoid theinaccurate dilution, or the use of unsafe water that may compromise the efficacy of ORS. To address this, ProlyteORS offers both W.H.O.-approved sachets and ready-to-drink formats (tetra packs), ensuring accuracy, hygiene and ease of administration.

For Cipla Health, reinforcing this distinction is essential to ensuring clarity in the category and adhering to regulatory guidance and responsible product labelling.

ORS products that follow the W.H.O. formula clearly mention it on the pack, enabling stakeholders to differentiate medically validated solutions from high sugar beverages.

In light of this ruling, Cipla Health strongly urges consumers to look for clear labelling and credible certifications when choosing oral rehydration solutions.